| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.5M | +13.8% |
| Cost of Revenue | $26.6M | +4.3% |
| Gross Profit | $3.5M | +60.4% |
| R&D Expense | $202K | +2.5% |
| SG&A Expense | $14.5M | -35.6% |
| Operating Income | -$11.0M | +45.9% |
| Interest Expense | $6.0M | +18.3% |
| Pre-tax Income | -$19.0M | +25.2% |
| Income Tax | -$67K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64K | — |
| Accounts Receivable | $2.6M | +34.7% |
| Inventory | $4.6M | -43.0% |
| Current Assets | $8.1M | -31.7% |
| Total Assets | $52.6M | -12.4% |
| Current Liabilities | $69.8M | +174.8% |
| Total Liabilities | $71.8M | +18.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | +56.3% |
| Investing Cash Flow | -$66K | +96.6% |
| Financing Cash Flow | $6.1M | -39.5% |
| +50.5% |
| Net Income | -$19.0M | +25.1% |
| EPS (Basic) | -$0.89 | +28.8% |
| EPS (Diluted) | -$0.89 | +28.8% |
| Stockholders' Equity |
| -$19.2M |
| -2663.5% |